Goldman Sachs’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$731K Sell
199,685
-222,345
-53% -$814K ﹤0.01% 4039
2025
Q1
$1.82M Sell
422,030
-234,126
-36% -$1.01M ﹤0.01% 3422
2024
Q4
$2.1M Buy
656,156
+383,525
+141% +$1.23M ﹤0.01% 3442
2024
Q3
$780K Buy
272,631
+24,681
+10% +$70.6K ﹤0.01% 3896
2024
Q2
$694K Buy
247,950
+61,083
+33% +$171K ﹤0.01% 3783
2024
Q1
$531K Sell
186,867
-17,131
-8% -$48.7K ﹤0.01% 3967
2023
Q4
$834K Sell
203,998
-67,955
-25% -$278K ﹤0.01% 3703
2023
Q3
$865K Buy
271,953
+55,957
+26% +$178K ﹤0.01% 3625
2023
Q2
$717K Sell
215,996
-398,588
-65% -$1.32M ﹤0.01% 3790
2023
Q1
$1.31M Sell
614,584
-161,068
-21% -$343K ﹤0.01% 3490
2022
Q4
$2.09M Sell
775,652
-191,444
-20% -$515K ﹤0.01% 3254
2022
Q3
$3.13M Sell
967,096
-81,215
-8% -$263K ﹤0.01% 3011
2022
Q2
$5.12M Buy
1,048,311
+124,825
+14% +$609K ﹤0.01% 2633
2022
Q1
$7.04M Buy
923,486
+91,143
+11% +$695K ﹤0.01% 2526
2021
Q4
$7.69M Buy
832,343
+80,810
+11% +$747K ﹤0.01% 2471
2021
Q3
$10.7M Sell
751,533
-400,890
-35% -$5.71M ﹤0.01% 2212
2021
Q2
$19.2M Buy
1,152,423
+1,057,263
+1,111% +$17.6M ﹤0.01% 1765
2021
Q1
$1.73M Buy
95,160
+26,476
+39% +$482K ﹤0.01% 3497
2020
Q4
$517K Buy
68,684
+39,597
+136% +$298K ﹤0.01% 3809
2020
Q3
$112K Sell
29,087
-25,489
-47% -$98.1K ﹤0.01% 4205
2020
Q2
$210K Buy
54,576
+36,520
+202% +$141K ﹤0.01% 3970
2020
Q1
$58K Sell
18,056
-1,075
-6% -$3.45K ﹤0.01% 4250
2019
Q4
$92K Buy
+19,131
New +$92K ﹤0.01% 4138
2019
Q2
Sell
-101,512
Closed -$761K 4255
2019
Q1
$761K Buy
+101,512
New +$761K ﹤0.01% 3385